↓ Skip to main content

Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine…

Overview of attention for article published in Trials, October 2020
Altmetric Badge

Mentioned by

news
9 news outlets
blogs
3 blogs
twitter
181 X users
wikipedia
9 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
225 Dimensions

Readers on

mendeley
952 Mendeley
Title
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
Published in
Trials, October 2020
DOI 10.1186/s13063-020-04775-4
Pubmed ID
Authors

Ricardo Palacios, Elizabeth González Patiño, Roberta de Oliveira Piorelli, Monica Tilli Reis Pessoa Conde, Ana Paula Batista, Gang Zeng, Qianqian Xin, Esper G. Kallas, Jorge Flores, Christian F. Ockenhouse, Christopher Gast

X Demographics

X Demographics

The data shown below were collected from the profiles of 181 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 952 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 952 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 195 20%
Student > Master 88 9%
Researcher 66 7%
Student > Ph. D. Student 59 6%
Other 42 4%
Other 140 15%
Unknown 362 38%
Readers by discipline Count As %
Medicine and Dentistry 232 24%
Nursing and Health Professions 90 9%
Pharmacology, Toxicology and Pharmaceutical Science 51 5%
Biochemistry, Genetics and Molecular Biology 37 4%
Immunology and Microbiology 26 3%
Other 125 13%
Unknown 391 41%